HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial
Authors:
- 20 May 2020
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (5) , 2306-2315
Abstract
Background The goal of this study is to evaluate the safety and efficacy of high intensity focused ultrasound (HIFU) for patients with colorectal liver metastases (CRLM) but were contraindicated for resection and radiofrequency ablation. Methods Patients between 20 and 80 years of age with 1–3 liver metastases from colorectal cancer were selected. Included patients have had their primary lesions removed with no evidence of extrahepatic metastasis prior to the study. Ultrasound-guided HIFU was employed and target regions’ ablation was achieved with repeated sonications from the deep to shallow regions of the tumors section by section. Results Thirteen patients were enrolled. The most common adverse events (AEs) were pain (n = 8), followed by fatigue (n = 7), increased aspartate aminotransferase (AST) (n = 7), increased alanine aminotransferase (ALT) (n = 5), and skin edema (n = 4). No grade ≥ 3 AEs occurred and while most patients (76.9%) achieved a complete response, three patients achieved a partial response. The objective response rate was 100% after the first HIFU treatment. Nine patients relapsed but the tumors were mostly isolated to the liver (8/9). The median follow-up period was 25 months. The 2-year progression-free survival (PFS) was 16.7%, and the median PFS was 9 months. Notably, the 2-year overall survival (OS) was 77.8%, and the median OS was 25 months. Conclusion This study indicates that the HIFU treatment is safe, is able to achieve a good tumor response rate and long-term prognosis even when the foci were in high-risk locations, and should be considered for patients who were considered unsuitable for other local treatments.Keywords
Funding Information
- the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (2018KY699, 2017KY138)
This publication has 35 references indexed in Scilit:
- Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasisSurgery, 2013
- Survival Analysis of High-Intensity Focused Ultrasound Therapy Versus Radiofrequency Ablation in the Treatment of Recurrent Hepatocellular CarcinomaAnnals of Surgery, 2013
- Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0Journal of the American Academy of Dermatology, 2012
- Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasisSurgical Endoscopy, 2012
- High-intensity focused ultrasound as a treatment for colorectal liver metastasis in difficult positionInternational Journal of Colorectal Disease, 2011
- High-Intensity Focused Ultrasound for Hepatocellular CarcinomaAnnals of Surgery, 2011
- High-Intensity Focused Ultrasound Ablation: Effective and Safe Therapy for Solid Tumors in Difficult LocationsAmerican Journal of Roentgenology, 2010
- High-Intensity Focused Ultrasound Ablation for the Treatment of Colorectal Liver Metastases During an Open ProcedureAnnals of Surgery, 2009
- Preliminary experience using high intensity focused ultrasound for treating liver metastasis from colon and stomach cancerInternational Journal of Hyperthermia, 2009
- Interstitial ablative techniques for hepatic tumoursBritish Journal of Surgery, 2003